S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ORKA Oruka Therapeutics Inc

10.53

0.00 (0.00%)

Pre Market

Last Updated: 06:40:32

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Oruka Therapeutics (NASDAQ:ORKA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Oruka Therapeutics Charts.

Oruka Therapeutics (NASDAQ:ORKA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Oruka Therapeutics Charts.

Oruka Therapeutics Inc News

Oruka Therapeutics to Present at Multiple March Investor Conferences
Wednesday 19 February 2025 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 5 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody
Thursday 19 December 2024 (2 months ago) • GlobeNewswire Inc.

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)
Wednesday 18 December 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Tuesday 26 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 21 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (3 months ago) • Edgar (US Regulatory)

More Oruka Therapeutics Inc News Articles

Bnp Paribas Issuance

Ls 3x Long Ferrari Race ...

Vontobel Financial Produ...

BNP Paribas Issuance

Societe Generale Effekten

Intesa Sanpaolo

Vontobel Financial Produ...

Vontobel Financial Produ...

Societe Generale Effekten

Global X Nasdaq 100 Cove...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions